0 CHECKOUT

Polio - Pipeline Review, H1 2015

  • ID: 3266301
  • April 2015
  • 63 pages
  • Global Markets Direct
1 of 4

FEATURED COMPANIES

  • Biological E. Limited
  • Codagenix, Inc.
  • Grifols, S.A.
  • Panacea Biotec Limited
  • Sanofi Pasteur SA
  • Sinovac Biotech Ltd.
  • MORE

Polio - Pipeline Review, H1 2015

Summary

This, ‘Polio - Pipeline Review, H1 2015’, provides an overview of the Polio’s therapeutic pipeline.

This report provides comprehensive information on the therapeutic development for Polio, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Polio and special features on late-stage and discontinued projects.

This report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from This proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by This team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles READ MORE >

Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Biological E. Limited
  • Codagenix, Inc.
  • Grifols, S.A.
  • Panacea Biotec Limited
  • Sanofi Pasteur SA
  • Sinovac Biotech Ltd.
  • MORE

List of Tables
List of Figures
Introduction
REPORT COVERAGE
Polio Overview
Therapeutics Development
Pipeline Products for Polio - Overview
Pipeline Products for Polio - Comparative Analysis
Polio - Therapeutics under Development by Companies
Polio - Therapeutics under Investigation by Universities/Institutes
Polio - Pipeline Products Glance
Late Stage Products
Clinical Stage Products
Early Stage Products
Unknown Stage Products
Polio - Products under Development by Companies
Polio - Products under Investigation by Universities/Institutes
Polio - Companies Involved in Therapeutics Development
Beijing Minhai Biotechnology Co., Ltd
Beijing Tiantan Biological Products Co., Ltd.
Bharat Biotech International Limited
Biological E. Limited
Codagenix, Inc.
Grifols, S.A.
Panacea Biotec Limited
Sanofi Pasteur SA
Sentinext Therapeutics Sdn Bhd
Sinovac Biotech Ltd.
Polio - Therapeutics Assessment
Assessment by Monotherapy Products
Assessment by Combination Products
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Drug Profiles
diphtheria + tetanus + pertussis (acellular) + haemophilus influenza [serotype B] + polio [sabin] vaccine - Drug Profile
Product Description
Mechanism of Action
R&D Progress
diphtheria + tetanus + pertussis (whole cell) + haemophilus influenzae [serotype B] + polio (pentavalent) vaccine - Drug Profile
Product Description
Mechanism of Action
R&D Progress
diphtheria + tetanus + pertussis (whole cell) + hepatitis B + haemophilus influenzae [serotype B] + polio (hexavalent) vaccine - Drug Profile
Product Description
Mechanism of Action
R&D Progress
diphtheria + tetanus + pertussis (whole-cell) + poliomyelitis + haemophilus influenzae [serotype B] + hepatitis B + meningococcal [serotype C] (7-valent) vaccine - Drug Profile
Product Description
Mechanism of Action
R&D Progress
diphtheria + tetanus+ pertussis (wholecell) + hepatitis [Type B] + poliomyelitis + haemophilus influenzae [type B] (hexavalent) vaccine - Drug Profile
Product Description
Mechanism of Action
R&D Progress
immune globulin (human) - Drug Profile
Product Description
Mechanism of Action
R&D Progress
IPVGVI-3000 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
polio (bivalent) virus like particle vaccine - Drug Profile
Product Description
Mechanism of Action
R&D Progress
polio (monovalent) vaccine - Drug Profile
Product Description
Mechanism of Action
R&D Progress
polio [sabin] vaccine - Drug Profile
Product Description
Mechanism of Action
R&D Progress
polio vaccine - Drug Profile
Product Description
Mechanism of Action
R&D Progress
polio vaccine - Drug Profile
Product Description
Mechanism of Action
R&D Progress
polio vaccine - Drug Profile
Product Description
Mechanism of Action
R&D Progress
polio vaccine [types 1, 2, 3] (monovalent) - Drug Profile
Product Description
Mechanism of Action
R&D Progress
poliomyelitis vaccine - Drug Profile
Product Description
Mechanism of Action
R&D Progress
PR-5I - Drug Profile
Product Description
Mechanism of Action
R&D Progress
V-073 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Polio - Recent Pipeline Updates
Polio - Dormant Projects
Polio - Discontinued Products
Polio - Product Development Milestones
Featured News & Press Releases
Oct 20, 2014: US FDA Accepts for Review a Biologics License Application for Merck and Sanofi Pasteur’s Investigational Pediatric Hexavalent Vaccine
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

List of Tables
Number of Products under Development for Polio, H1 2015
Number of Products under Development for Polio - Comparative Analysis, H1 2015
Number of Products under Development by Companies, H1 2015
Number of Products under Investigation by Universities/Institutes, H1 2015
Comparative Analysis by Late Stage Development, H1 2015
Comparative Analysis by Clinical Stage Development, H1 2015
Comparative Analysis by Early Stage Development, H1 2015
Comparative Analysis by Unknown Stage Development, H1 2015
Products under Development by Companies, H1 2015
Products under Investigation by Universities/Institutes, H1 2015
Polio - Pipeline by Beijing Minhai Biotechnology Co., Ltd, H1 2015
Polio - Pipeline by Beijing Tiantan Biological Products Co., Ltd., H1 2015
Polio - Pipeline by Bharat Biotech International Limited, H1 2015
Polio - Pipeline by Biological E. Limited, H1 2015
Polio - Pipeline by Codagenix, Inc., H1 2015
Polio - Pipeline by Grifols, S.A., H1 2015
Polio - Pipeline by Panacea Biotec Limited, H1 2015
Polio - Pipeline by Sanofi Pasteur SA, H1 2015
Polio - Pipeline by Sentinext Therapeutics Sdn Bhd, H1 2015
Polio - Pipeline by Sinovac Biotech Ltd., H1 2015
Assessment by Monotherapy Products, H1 2015
Assessment by Combination Products, H1 2015
Number of Products by Stage and Target, H1 2015
Number of Products by Stage and Mechanism of Action, H1 2015
Number of Products by Stage and Route of Administration, H1 2015
Number of Products by Stage and Molecule Type, H1 2015
Polio Therapeutics - Recent Pipeline Updates, H1 2015
Polio - Dormant Projects, H1 2015
Polio - Discontinued Products, H1 2015

List of Figures
Number of Products under Development for Polio, H1 2015
Number of Products under Development for Polio - Comparative Analysis, H1 2015
Number of Products under Development by Companies, H1 2015
Number of Products under Investigation by Universities/Institutes, H1 2015
Comparative Analysis by Clinical Stage Development, H1 2015
Comparative Analysis by Early Stage Products, H1 2015
Assessment by Monotherapy Products, H1 2015
Assessment by Combination Products, H1 2015
Number of Products by Top 10 Targets, H1 2015
Number of Products by Stage and Top 10 Targets, H1 2015
Number of Products by Top 10 Mechanism of Actions, H1 2015
Number of Products by Stage and Top 10 Mechanism of Actions, H1 2015
Number of Products by Top 10 Routes of Administration, H1 2015
Number of Products by Stage and Top 10 Routes of Administration, H1 2015
Number of Products by Top 10 Molecule Types, H1 2015
Number of Products by Stage and Top 10 Molecule Types, H1 2015

Note: Product cover images may vary from those shown
3 of 4

Beijing Minhai Biotechnology Co., Ltd
Beijing Tiantan Biological Products Co., Ltd.
Bharat Biotech International Limited
Biological E. Limited
Codagenix, Inc.
Grifols, S.A.
Panacea Biotec Limited
Sanofi Pasteur SA
Sentinext Therapeutics Sdn Bhd
Sinovac Biotech Ltd.

Note: Product cover images may vary from those shown
4 of 4
Note: Product cover images may vary from those shown

PURCHASING OPTIONS

HAVE A QUESTION?

EMAIL US VIEW FAQs

RELATED PRODUCTS from Db

Our Clients

  • Genentech, Inc.
  • GlaxoSmithKline PLC
  • Maquet Getinge Group
  • Emergent BioSolutions, Inc.
  • Aicuris GmbH & Co.KG
  • Merck & Co., Inc.